Galen Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Galen Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3409
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galen Ltd (Galen), a subsidiary of Almac Group Ltd, is a pharmaceutical company. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angina, constipation, HIV-related Kaposi’s sarcoma (KS), osteoporosis, overactive bladder, painful bladder syndrome and interstitial cystitis, and skin lesions and warts. Galen partners with international pharmaceutical and biotech companies to commercialize and expand its products. The company markets its products across the UK, Ireland, Europe and the US. It operates in the UK and the US. Galen is headquartered in Craigavon, the UK.

Galen Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galen Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Galen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galen Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Galen Acquires US Rights to ADASUVE from Alexza Pharma 11
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 12
Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13
Licensing Agreements 14
Galen Enters Into Licensing Agreement With Medical Developments International For Penthrox 14
Galen Ltd – Key Competitors 15
Galen Ltd – Key Employees 16
Galen Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Galen Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galen Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Galen Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Galen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galen Acquires US Rights to ADASUVE from Alexza Pharma 11
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 12
Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13
Galen Enters Into Licensing Agreement With Medical Developments International For Penthrox 14
Galen Ltd, Key Competitors 15
Galen Ltd, Key Employees 16
Galen Ltd, Subsidiaries 17

List of Figures
Galen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galen Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Galen Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BGFIBank Group:企業の戦略・SWOT・財務分析
    BGFIBank Group - Strategy, SWOT and Corporate Finance Report Summary BGFIBank Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Steris PLC:企業の戦略・SWOT・財務情報
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Seneca Biopharma Inc (CUR):企業の財務・戦略的SWOT分析
    Summary Seneca Biopharma Inc(Seneca) formerly known as Neuralstem Inc, is a biopharmaceutical company that develops novel treatments for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer’s di …
  • QHR Corporation:医療機器:M&Aディール及び事業提携情報
    Summary QHR Corporation (QHR), a subsidiary of Shoppers Drug Mart Inc. (SDMI), formerly known as QHR Technologies Inc., is a healthcare technology provider. It offers electronic medical records (EMR) for healthcare professionals including family physicians, medical specialists, and surgeons. The com …
  • Senex Energy Ltd (SXY):企業の財務・戦略的SWOT分析
    Summary Senex Energy Ltd (Senex) is an independent upstream oil and gas company. It mainly focuses on the east coast of Australia. The company acquires, explores, and develops oil and gas assets in the Surat and Cooper basins. It owns significant acreage in the basins with operatorship over all of i …
  • GMT Exploration Co LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary GMT Exploration Co LLC (GMT Exploration) is a oil and natural gas company. It is engaged in the generation, operation and development of oil and natural gas properties primarily located in Alaska, East Texas, Montana, New Mexico and Wyoming. The Company’s identifies, acquires and operates re …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Hydro One Ltd (H)-エネルギー分野:企業M&A・提携分析
    Summary Hydro One Limited (Hydro One) is a utility holding company that conducts electricity transmission and distribution, and telecom businesses in Ontario through its subsidiaries. The company serves residential, commercial and industrial customers. It serves large industrial customers through hi …
  • G&K Services LLC:戦略・SWOT・企業財務分析
    G&K Services LLC - Strategy, SWOT and Corporate Finance Report Summary G&K Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Epcor Utilities Inc-エネルギー分野:企業M&A・提携分析
    Summary Epcor Utilities Inc. (Epcor), a subsidiary of City of Edmonton, is an energy utility which offers electricity and water services. It builds, owns and operates electrical transmission and distribution networks; and water and wastewater treatment facilities and infrastructure. The company prov …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …
  • Amazon Web Services Inc:企業の戦略・SWOT・財務分析
    Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report Summary Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • OHB SE:企業の戦略・SWOT・財務情報
    OHB SE - Strategy, SWOT and Corporate Finance Report Summary OHB SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Cancer Research Technology Ltd.:企業のM&A・事業提携・投資動向
    Cancer Research Technology Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cancer Research Technology Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • CFF GmbH & Co KG:戦略・SWOT・企業財務分析
    CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • McColl’s Retail Group Plc (MCLS):企業の財務・戦略的SWOT分析
    McColl's Retail Group Plc (MCLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • NanoCarrier Co Ltd (4571):企業の財務・戦略的SWOT分析
    Summary NanoCarrier Co Ltd (NanoCarrier) is a drug development company that develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s pipeline products include NC-6004, NC-4016, NC-6300, VB-111, NC-6201 and NK105. It offers siRNA micelle, protein micelle, DACH-plat …
  • Savencia SA:企業の戦略・SWOT・財務情報
    Savencia SA - Strategy, SWOT and Corporate Finance Report Summary Savencia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆